sugemalimab
·Code: EQ165, CS1001
sugemalimab: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| EQRx, Inc. (EQRX) | Phase 3 |
Get deeper analysis on sugemalimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis